Balancing repair and tolerance of DNA damage caused by alkylating agents
Alkylating agents constitute a major class of frontline chemotherapeutic drugs that inflict cytotoxic DNA damage as their main mode of action, in addition to collateral mutagenic damage. Numerous cellular pathways, including direct DNA damage reversal, base excision repair (BER) and mismatch repair...
Main Authors: | Fu, Dragony, Calvo, Jennifer A., Samson, Leona D |
---|---|
Other Authors: | Massachusetts Institute of Technology. Center for Environmental Health Sciences |
Format: | Article |
Language: | en_US |
Published: |
Nature Publishing Group
2014
|
Online Access: | http://hdl.handle.net/1721.1/88982 https://orcid.org/0000-0002-7112-1454 |
Similar Items
-
DNA repair modulates the vulnerability of the developing brain to alkylating agents
by: Samson, Leona D., et al.
Published: (2011) -
Direct repair of 3,N[superscript 4]-ethenocytosine by the human ALKBH2 dioxygenase is blocked by the AAG/MPG glycosylase
by: Fu, Dragony, et al.
Published: (2015) -
The interaction between ALKBH2 DNA repair enzyme and PCNA is direct, mediated by the hydrophobic pocket of PCNA and perturbed in naturally-occurring ALKBH2 variants
by: Hübscher, Ullrich, et al.
Published: (2017) -
DNA Alkylation Damage by Nitrosamines and Relevant DNA Repair Pathways
by: Jörg Fahrer, et al.
Published: (2023-02-01) -
Aag DNA Glycosylase Promotes Alkylation-Induced Tissue Damage Mediated by Parp1
by: Calvo, Jennifer A., et al.
Published: (2013)